Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

Versatile Code Reading Software for Sample Storage
Saturday, October 04, 2014
New software is easy to install, gives reliable code readings and can be smoothly integrated into any laboratory sample database.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

New CombiCult® Technology Massively Accelerates Development of Stem Cell Cures
Friday, September 26, 2014
CombiCult® technology enables a single scientist to carry out 10,000 stem cell biology experiments in parallel.

Worthington Biochemical Introduces AOF Collagenase/Neutral Protease Blends
Wednesday, September 24, 2014
Collagenase/neutral protease blends from bacterial source minimize contamination threat.

Abzena Appoints Experts for Relocation to New Headquarters
Wednesday, September 10, 2014
Laboratory relocation specialist Andrew Porter Limited has completed the move of PolyTherics, a wholly owned subsidiary of Abzena, to the Babraham Research Campus in Cambridge.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

PerkinElmer Launches Innovative Multiplexing System
Thursday, September 04, 2014
AlphaPlex™ reagent technology provides life sciences researchers with more data in less time.

CCRM Uses ambr15 for Pluripotent Stem Cell Expansion
Tuesday, August 05, 2014
New protocols increase stem cell expansion outputs and improve differentiation into cardiomyocytes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 484
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv